82 related articles for article (PubMed ID: 22439598)
1. Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition.
Wang CC; Liau JY; Lu YS; Chen JW; Yao YT; Lien HC
Histopathology; 2012 Jul; 61(1):78-87. PubMed ID: 22439598
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
[TBL] [Abstract][Full Text] [Related]
3. Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression.
Logullo AF; Nonogaki S; Pasini FS; Osório CA; Soares FA; Brentani MM
Oncol Rep; 2010 Feb; 23(2):313-20. PubMed ID: 20043090
[TBL] [Abstract][Full Text] [Related]
4. 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells.
Lehtinen L; Vainio P; Wikman H; Reemts J; Hilvo M; Issa R; Pollari S; Brandt B; Oresic M; Pantel K; Kallioniemi O; Iljin K
J Pathol; 2012 Mar; 226(4):674-86. PubMed ID: 22072156
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.
Lien HC; Lee YH; Jeng YM; Lin CH; Lu YS; Yao YT
Histopathology; 2014 Sep; 65(3):328-39. PubMed ID: 24527698
[TBL] [Abstract][Full Text] [Related]
6. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype.
Jeong H; Ryu YJ; An J; Lee Y; Kim A
Histopathology; 2012 May; 60(6B):E87-95. PubMed ID: 22439911
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
9. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
10. Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma.
Köbel M; Gradhand E; Zeng K; Schmitt WD; Kriese K; Lantzsch T; Wolters M; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
Int J Gynecol Pathol; 2006 Apr; 25(2):121-30. PubMed ID: 16633060
[TBL] [Abstract][Full Text] [Related]
11. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
Weigelt B; Kreike B; Reis-Filho JS
Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
[TBL] [Abstract][Full Text] [Related]
12. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
[TBL] [Abstract][Full Text] [Related]
14. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
Kleer CG; Griffith KA; Sabel MS; Gallagher G; van Golen KL; Wu ZF; Merajver SD
Breast Cancer Res Treat; 2005 Sep; 93(2):101-10. PubMed ID: 16187229
[TBL] [Abstract][Full Text] [Related]
15. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.
Sitterding SM; Wiseman WR; Schiller CL; Luan C; Chen F; Moyano JV; Watkin WG; Wiley EL; Cryns VL; Diaz LK
Ann Diagn Pathol; 2008 Feb; 12(1):33-40. PubMed ID: 18164413
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal transition in carcinomas of the female genital tract.
Stewart CJ; McCluggage WG
Histopathology; 2013 Jan; 62(1):31-43. PubMed ID: 23240668
[TBL] [Abstract][Full Text] [Related]
17. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
Grönberg M; Fjällskog ML; Jirström K; Janson ET
Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
[TBL] [Abstract][Full Text] [Related]
18. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
[TBL] [Abstract][Full Text] [Related]
19. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
20. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
